Search Prime Grants

U54CA196519

Cooperative Agreement

Overview

Grant Description
Developmental and hyperactive RAS tumor spore.
Awardee
Trustees Of Indiana University
Funding Goals
TO PROVIDE AN ORGANIZATIONAL FOCUS AND STIMULUS FOR THE HIGHEST QUALITY CANCER RESEARCH THAT EFFECTIVELY PROMOTES INTERDISCIPLINARY CANCER RESEARCH AIMED TOWARD THE ULTIMATE GOAL OF REDUCING CANCER INCIDENCE, MORTALITY AND MORBIDITY. THE CANCER CENTER SUPPORT GRANT (CCSG) PROVIDES THE RESOURCES AND INFRASTRUCTURE TO FACILITATE THE COORDINATION OF INTERDISCIPLINARY PROGRAMS ACROSS A BROAD SPECTRUM OF RESEARCH FROM BASIC LABORATORY RESEARCH TO CLINICAL INVESTIGATION TO POPULATION SCIENCE. THE CCSG SUPPORTS SALARIES FOR SCIENTIFIC LEADERSHIP OF THE CENTER, SHARED RESOURCES FOR FUNDED CENTER INVESTIGATORS, CERTAIN ADMINISTRATIVE COSTS, PLANNING AND EVALUATION, AND DEVELOPMENTAL FUNDS FOR NEW RECRUITMENTS AND FEASIBILITY STUDIES.
Grant Program (CFDA)
93.397 - Cancer Centers Support Grants
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
Indianapolis, Indiana 462025254 United States
Geographic Scope
Single Zip Code
Related Opportunity
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50) (PAR-18-313)
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/20 to 08/31/26 and the total obligations have increased 808% from $2,185,000 to $19,832,439.
Trustees Of Indiana University was awarded Developmental and Hyperactive Ras Tumor (DHART) SPORE Cooperative Agreement U54CA196519 worth $19,832,439 from National Cancer Institute in September 2015 with work to be completed primarily in Indianapolis Indiana United States. The grant has a duration of 11 years and was awarded through assistance program 93.397 Cancer Centers Support Grants. The Cooperative Agreement was awarded through grant opportunity Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50).

Status
(Ongoing)

Last Modified 9/24/25

Period of Performance
9/1/15
Start Date
8/31/26
End Date
92.0% Complete

Funding Split
$19.8M
Federal Obligation
$0.0
Non-Federal Obligation
$19.8M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U54CA196519

Transaction History

Modifications to U54CA196519

Additional Detail

Award ID FAIN
U54CA196519
SAI Number
U54CA196519-4226205178
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NC00 NIH National Cancer Institute
Awardee UEI
SHHBRBAPSM35
Awardee CAGE
434D9
Performance District
IN-07
Senators
Todd Young
Mike Braun

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $17,275,028 100%
Modified: 9/24/25